drugset / Trial / NCT01614951

The Pulmonary Protection Trial

NCT01614951 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to investigate whether patients with a preoperative reduced pulmonary function have a better preserved oxygenation capacity after open heart surgery, using either pulmonary perfusion or pulmoplegia compared with TAVI and the control-group with standard ECC (Extra Corporal Circulation).

Timeline

Start
2012-07
Primary completion
2013-11
Completion
2013-11

Outcome

Mixed primary results

paper The coprimary outcomes were the inverse oxygenation index compared at 21 hours after starting CPB and longitudinally in a mixed-effects model (MEM). PMID 27651908 ↗

paper had a higher oxygenation index compared with no pulmonary perfusion (mean difference (MD) 0.94; 95% CI 0.05 to 1.83; p=0.04). PMID 27651908 ↗

paper Yet the blood or HTK groups did not demonstrate a longitudinally higher oxygenation index compared with no pulmonary perfusion (MEM, p=0.57 and 0.17). PMID 27651908 ↗

paper no difference in the oxygenation index between the HTK group and those no pulmonary perfusion (MD 0.06; 95% CI -0.73 to 0.86; p=0.87). PMID 27651908 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject HTK Custodiol Unknown — —